Associations among serum markers of inflammation, life stress and suicide risk in patients with major depressive disorder
Introduction
Suicide - a fatal act of intentionally causing one's own death - is the worst outcome of major depressive disorder (MDD) (Turecki and Brent, 2016). The clinical spectrum of suicidal behavior is heterogeneous and varies in the degree of suicidal intent, severity and adversely impacts clinical outcome. Noteworthy, troubling evidence suggests that a considerable percentage of suicidal individuals hide their suicidal intent from others (Friedlander et al., 2012). Reliable predictors of completed suicides have included prior suicide attempts (Da Cruz et al., 2011) and life-time or current history of psychiatric disorders, including MDD (Arsenault-Lapierre et al., 2004). In parallel with international literature, a comprehensive meta-analysis of Chinese MDD patients indicated worrisome trends with pooled lifetime prevalence rates of 53.1% (from 11 studies), 17.5% (from 4 studies) and 23.7% (from 18 studies) for suicidal ideation, plan and attempts, respectively (Dong et al., 2018).
Despite considerable linking suicide with MDD, identifying individuals at risk has remained a challenge (Hawton et al., 2013). Younger age (Chen et al., 2014; Holma et al., 2010), male gender (Chen et al., 2014; Hawton et al., 2013), cigarette smoking (Oquendo et al., 2007), unemployment (Chen et al., 2014), aggressive traits (Keilp et al., 2006), hopelessness (Hawton et al., 2013), low social support (Holma et al., 2010; Lin et al., 2020), exposure to early-life adversities (Brodsky et al., 2001) and stressful life events (Lin et al., 2018; Oquendo et al., 2013; Park et al., 2015) have all been implicated as risk factors. In addition to the diagnosis of depression and presence of melancholia (Hawton et al., 2013) and psychotic symptoms (Chen et al., 2014), other psychiatric disorders (psychosis, anxiety (Hawton et al., 2013), borderline personality disorder (Soloff et al., 2000), substance abuse disorders (Dalca et al., 2013; Hawton et al., 2013)) and medical comorbidities (such as diabetes) (Goodwin et al., 2003; O'Connor and Nock, 2014) have also been identified as key risk factors. Key questions still remain unanswered including how long does this risk last, how it evolves over the entire period of a depressive episode and at what point can we say when such risk has abated.
It is likely that biomarkers reflective of pathophysiological processes leading to the expression of suicidal behavior in MDD patients would be of great help. Several strategies have been applied to investigate the biomarker profile of suicide. Peripheral biomarker studies have attracted considerable interest due to advantages, such as availability, lower costs and lower invasiveness of the procedures. Findings from peripheral biomarkers have highlighted that serum and plasma biomarkers may help recognize suicide risks in MDD patients. Recent data of peripheral biomarkers for suicide in MDD have implicated enhanced inflammatory activity (Grudet et al., 2014; Janelidze et al., 2011; O'Donovan et al., 2013), altered energy metabolism (Baek et al., 2014; Park et al., 2014; Ruljancic et al., 2011; Segoviano-Mendoza et al., 2018), dysfunctional HPA axis activity (Brunner et al., 2002; McGirr et al., 2011), decreased neurotrophic support (Deveci et al., 2008; Kim et al., 2007; Lee et al., 2007) and reduced monoamine levels (Ruljancic et al., 2011; Spreux-Varoquaux et al., 2001).
However, results from peripheral studies are mixed and do not provide a coherent view. Firstly, a possible explanation for mixed findings could be the biological heterogeneity that underlies MDD and suicidal behavior. Probably, dysfunction of specific biological mechanism is more prominent in distinct subsets of patients, while other mechanisms may be more significant in others. Therefore, single biomarker may have weak predictive ability of suicidality in MDD patients. Secondly, confounding variables such as the severity of depression (Hawton et al., 2013), psychiatric (Dalca et al., 2013; Hawton et al., 2013; Soloff et al., 2000) and physical (Goodwin et al., 2003) comorbidities, medications (Sen et al., 2008), and childhood (Brodsky et al., 2001) and adulthood (Oquendo et al., 2013) adversity that may affect both the risk of suicide and the peripheral levels of biomarkers in MDD patients may need to be accounted for.
In summary, the pathogenesis of suicide is complex, involving clinical, psychological, sociological and biological factors, and these factors interact with each other (Turecki and Brent, 2016). Therefore, this study investigated a comprehensive range of serum markers that were sampled concurrently and have been previously linked to suicide (23 targeted biomarkers reflecting immune, neurotrophic, HPA-axis and metabolic parameters), psychological stress (life adversities in the childhood and adulthood) and clinical characteristics (psychiatric and physical comorbidities, severity of depression) in MDD patients. The primary aim was to test the hypothesis that MDD patients who had suicide risk will demonstrate combinatorial profile of serum biomarkers that discriminate them from those without suicide risk. A secondary aim was to validate the hypothesis that the effects of psychological stress and adversity on increasing the acute/proximal risk of suicide will be mediated by above mentioned serum biomarker profile.
Section snippets
Subjects
Subject data were derived from the Objective Diagnostic Markers and Personalized Intervention in MDD patients (ODMPIM). This protocol was approved and monitored by the Ethic Committee of Peking University Sixth Hospital (Approval No.2013-29-1). All patients and healthy controls gave written informed consent before they participated in this study. Details on this protocol are presented elsewhere (Lv et al., 2016). Briefly, ODMPIM study was conducted in 9 centers of China. Patients aged 18–55
Results
A total of 168 patients with MDD, including 50 patients with suicide risk (age: 35.9 ± 11.3) and 118 patients without (age: 39 ± 10.7) suicide risk were recruited. In patients with suicide risk, 12 patients were recent suicide attempters over the past month, and 9 patients had a history of suicide attempts. The demographic data are presented in Table 1. There were no differences in age, gender, body mass index (BMI), education level, smoking, drinking, marriage and employment status between the
Discussion
Using 23 evidence-based peripheral biomarkers, we found that MDD patients with suicide risk had higher serum level of CXCL-1, also had an elevated inflammatory index (a composite index of inflammatory activation) than patients without suicide risk. In addition, higher proportion of adulthood adversity was found in patients with suicide risk. Path analysis indicated that severity of depression and inflammatory index may mediate the relationship between adulthood adversity and suicide risk.
CRediT authorship contribution statement
Yun-Ai Su: Conceptualization, Funding acquisition, Investigation, Formal analysis, Writing - original draft, Writing - review & editing. Jing-Yu Lin: Conceptualization, Formal analysis, Software, Writing - original draft. Qi Liu: Data curation, Investigation, Project administration, Resources. Xiao-Zhen Lv: Methodology, Data curation, Project administration. Gang Wang: Methodology, Project administration, Resources. Jing Wei: Methodology, Project administration, Resources. Gang Zhu:
Declaration of competing interest
All the other authors declare that they have no conflict of interest.
Acknowledgements
This study was supported by grants from the National Key Basic Research Program of China (973 Program) (No. 2013CB531305), the National Natural Science Foundation of China (No.81771468, 81630031), the National Key Technology R and D Program (No. 2015BAI13B01), the Beijing Municipal Science and Technology Project (No. Z171100000117016).
References (73)
- et al.
Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
(2014) - et al.
Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results
Eur. Neuropsychopharmacol
(2002) - et al.
Enhancement of macrophage inflammatory responses by CCL2 is correlated with increased miR-9 expression and downregulation of the ERK1/2 phosphatase Dusp6
Cell. Immunol.
(2017) - et al.
The relationships of current suicidal ideation with inflammatory markers and heart rate variability in unmedicated patients with major depressive disorder
Psychiatr. Res.
(2017) - et al.
Suicide risk in major affective disorder: results from a national survey in China
J. Affect. Disord.
(2014) - et al.
Prevalence of suicidal behaviors in patients with major depressive disorder in China: a comprehensive meta-analysis
J. Affect. Disord.
(2018) - et al.
Anti-inflammatory effects of an inflammatory chemokine: CCL2 inhibits lymphocyte homing by modulation of CCL21-triggered integrin-mediated adhesions
Blood
(2008) - et al.
Peripheral chemokine levels in women with recurrent major depression with suicidal ideation
Rev. Bras. Psiquiatr.
(2012) - et al.
Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood
Psychoneuroendocrinology
(2014) - et al.
Risk factors for suicide in individuals with depression: a systematic review
J. Affect. Disord.
(2013)
Cytokine levels in the blood may distinguish suicide attempters from depressed patients
Brain Behav. Immun.
Low plasma BDNF is associated with suicidal behavior in major depression
Prog. Neuro-Psychopharmacol. Biol. Psychiatry
Decreased plasma BDNF level in depressive patients
J. Affect. Disord.
Perceived stressfulness mediates the effects of subjective social support and negative coping style on suicide risk in Chinese patients with major depressive disorder
J. Affect. Disord.
Harm avoidance moderates the influence of serotonin transporter gene variants on treatment outcome in bipolar patients
J. Affect. Disord.
Personal and family history of suicidal behaviour is associated with lower peripheral cortisol in depressed outpatients
J. Affect. Disord.
The psychology of suicidal behaviour
Lancet Psychiatr.
Toll-like receptors in the depressed and suicide brain
J. Psychiatr. Res.
The association of suicide risk with negative life events and social support according to gender in Asian patients with major depressive disorder
Psychiatr. Res.
The association between serum lipid levels, suicide ideation, and central serotonergic activity in patients with major depressive disorder
J. Affect. Disord.
Serum brain-derived neurotrophic factor levels in subjects with major depressive disorder with previous suicide attempt: a population-based study
Psychiatr. Res.
Prolactin and thyroid hormone levels are associated with suicide attempts in psychiatric patients
Psychiatr. Res.
Temperaments mediate suicide risk and psychopathology among patients with bipolar disorders
Compr. Psychiatr.
Thrombocyte serotonin and serum cholesterol concentration in suicidal and non-suicidal depressed patients
Prog. Neuro Psychopharmacol. Biol. Psychiatr.
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications
Biol. Psychiatr.
Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters: relationships with impulsivity and depression
Life Sci.
Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide
J. Psychiatr. Res.
Inflammation and clinical response to treatment in depression: a meta-analysis
Eur. Neuropsychopharmacol
Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder
Brain Behav. Immun.
Suicide and suicidal behaviour
Lancet
The neurobiology of suicide
Lancet Psychiatr.
Serum levels of nerve growth factor (NGF) in patients with major depression disorder and suicide risk
J. Affect. Disord.
Psychiatric diagnoses in 3275 suicides: a meta-analysis
BMC Psychiatr.
Childhood Trauma Questionnaire: A Retrospective Self-Report: Manual
The relationship of childhood abuse to impulsivity and suicidal behavior in adults with major depression
Am. J. Psychiatr.
Role of inflammation in suicide: from mechanisms to treatment
Neuropsychopharmacology
Cited by (15)
Proinflammatory phenotype in major depressive disorder with adulthood adversity: In line with social signal transduction theory of depression
2023, Journal of Affective DisordersSuicidality in civilian women with PTSD: Possible link to childhood maltreatment, proinflammatory molecules, and their genetic variations
2023, Brain, Behavior, and Immunity - HealthDepression in breast cancer patients: Immunopathogenesis and immunotherapy
2022, Cancer LettersCitation Excerpt :In addition to its chemotactic role, IL-8 stimulates neutrophils to produce net-like structures that assist breast cancer cell migration [99]. Whereas CXCL1 promotes neutrophil migration and transmigration across the BBB [100], its levels are strongly associated with suicidal behavior in depression [101]. DCs participate in innate and adaptive immune responses.
Molecular Changes Associated with Suicide
2023, International Journal of Molecular SciencesPeripheral Markers of Suicidal Behavior: Current Findings and Clinical Implications
2023, Clinical Psychopharmacology and Neuroscience
- 1
Yun-Ai Su and Jing-Yu Lin contributed equally to this work.